Please login to the form below
Mallinckrodt
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.
Mallinckrodt files for bankruptcy protection in the US
Within that settlement, Mallinckrodt said it will pay plaintiffs $1.6bn over eight years to mitigate accusations over its involvement in the epidemic. ... The bankruptcy filing will reduce Mallinckrodt’s debt by approximately $1.3bn and resolve the
AstraZeneca forms $2bn gene silencing pact with Silence Tx
tissues. This is the second $2bn-plus alliance for Silence, coming after Irish drugmaker Mallinckrodt paid $25m upfront last year for a project that will develop siRNA drugs targeting the complement
Coronavirus disruption scuppers Curium Pharma sale
Paris-headquartered Curium was formed three years ago via the merger of CapVest’s IBA Molecular with the nuclear medicines business of Ireland-listed drugmaker Mallinckrodt.
US piles pressure on Mallinckrodt over alleged Acthar fraud
Drugmaker allegedly underpaid rebates owed to Medicaid. The US government has filed a lawsuit against Mallinckrodt, claiming that the drugmaker defrauded Medicaid by underpaying rebates owed to the federal health insurance ... The NDA approval was
Mallinckrodt reaches tentative $1.6bn opioid settlement
Mallinckrodt’s speciality US generics business – which includes its opioid drug franchise – will file for chapter 11 bankruptcy protection as part of the wide-scale agreement. ... Last September, Mallinckrodt sold off its contract development and
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Nucleus Global announces a trio of promotions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Pfizer introduces new logo in a ‘shift from commerce to science’
- PHE study finds people who have had COVID-19 can still transmit the virus
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
